She changed her diet and maintained a strict workout regimen. But since there were no results, Williams turned to GLP-1 ...

Serena Williams is serving up an honest look into her weight loss. The tennis star—who shares daughters Alexis, 6, and Adira, ...

For reasons that remain unclear, kidney cancer risk was higher in users of GLP-1 agonists, particularly those under 65 and ...

GLP-1 receptor agonists may reduce cancer risk among people with obesity or overweight, according to retrospective study results.Adults who used GLP-1 medications exhibited a statistically significant ...

Serena Williams has been taking a GLP-1 medication to help with her recent weight loss, she revealed for the first time in an exclusive TODAY interview.

Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing cancer risk among patients with obesity, particularly for endometrial, ovarian, and meningioma cancers.

The FDA has approved Signos, the first glucose monitoring app using AI to help users lose weight and track real-time food ...

Williams joins a growing list of celebrities who have publicly shared their use of weight loss medications, including Oprah Winfrey, Whoopi Goldberg, singer Meghan Trainor and basketball legend ...

An observational study published in JAMA Oncology looks at GLP-1 receptor agonists and cancer risk in adults with obesity. Prof Paul Pharoah, Professor of Cancer Epidemiology, Cedars-Sinai Medical ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Tennis legend Serena Williams is sharing her journey with weight loss drugs, saying she's lost 31 pounds in 8 months using ...

Serena Williams shares her weight loss journey, revealing she lost 31 pounds using GLP-1 medication after her second child.